Management of Threatened Preterm Labor by Cervical Length-based Approach or Conventional Approach

August 5, 2021 updated by: Kuntharee Traisrisilp, ChaingMai University

A Comparison of the Effectiveness in Management of Threatened Preterm Labor Between Cervical Length-based Approach and Conventional Approach: A Randomized Control Trial

To compare the effectiveness of treatment of threatened preterm labor between transvaginal cervical length-based approach and conventional approach (Per vaginal examination)

Study Overview

Status

Withdrawn

Intervention / Treatment

Study Type

Interventional

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Chiang Mai, Thailand, 50200
        • Kuntharee Traisrisilp
      • ChiangMai, Thailand, 50200
        • Maharaj Nakorn Chiangmai Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Pregnant with symptoms of threatened preterm labor which refer to regular uterine contractions at least 1 time in every 10 minutes and persist for 30 minute without cervical dilatation or cervical dilation ≤ 1 cm and < 80% of effacement.
  • Age ≥ 18 years
  • Singleton pregnancy
  • 24 0/7 - 33 6/7 weeks of gestation
  • Uneventful antenatal care or low-risk pregnancies

Exclusion Criteria:

  • The definitive diagnosis of true labor
  • Proceed to the active phase of labor
  • Age < 18 years
  • Multiple pregnancies
  • < 24 or ≥ 34 weeks of gestation
  • Fetal chromosomal or structural abnormalities
  • Abnormal fetal growth
  • Abnormal amniotic fluid
  • Evidence of placenta previa
  • Significant vaginal bleeding that cannot be ruled out placenta previa
  • Evidence of rupture of membranes
  • Evidence of intrauterine infection
  • Evidence of uterine malformation
  • Evidence of lethal fetal malformation
  • Unable to communicate or understand the information of the study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: PREVENTION
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: TVCL-based
Monitor progression of labor by shortening of cervix examined by transvaginal cervical length
Transvaginal ultrasound to measure cervical length if persist regular uterine contraction
ACTIVE_COMPARATOR: Conventional-based
Monitor progression of labor by per vaginal exam to detect cervical change
Transvaginal ultrasound to measure cervical length if persist regular uterine contraction

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of cases with delivery within 7 day after admission
Time Frame: From admission to no uterine contraction in 10 minute
In case of threatened preterm labor if detection the progression of labor by transvaginal cervical length, the rate of delivery within 7 days will less or more than conventional group.
From admission to no uterine contraction in 10 minute

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The number of tocolysis courses, length of hospital stay
Time Frame: From admission to no uterine contraction in 10 minute
In case of tocolytic used for stop labor. The number of medication will be recorded.
From admission to no uterine contraction in 10 minute
The number of steroid courses
Time Frame: From admission to no uterine contraction in 10 minute
In case of stop labor, the course of steroid for promote lung maturity is recorded.
From admission to no uterine contraction in 10 minute

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

January 22, 2020

Primary Completion (ACTUAL)

May 4, 2020

Study Completion (ANTICIPATED)

January 1, 2021

Study Registration Dates

First Submitted

March 6, 2020

First Submitted That Met QC Criteria

March 6, 2020

First Posted (ACTUAL)

March 10, 2020

Study Record Updates

Last Update Posted (ACTUAL)

August 9, 2021

Last Update Submitted That Met QC Criteria

August 5, 2021

Last Verified

August 1, 2021

More Information

Terms related to this study

Other Study ID Numbers

  • OBG-2562-06699

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Transvaginal ultrasound

3
Subscribe